Inventor · disambiguated record
Margo P. Cohen
Also filed as: COHEN MARGO · COHEN MARGO P
11 granted patents·3 pending applications·241 citations·filing 1988–2015
91Inventor score
Top patents by PatentIndex Score
14 records- 0186US5223392AMonoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use thereforeEXOCELL INC·Filed 1988·Granted Jun 29, 1993·62 cites·13 claims
- 0283US6552077B2Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologiesEXOCELL INC·Filed 2001·Granted Apr 22, 2003·17 cites·9 claims
- 0376US5518720ATreatment of complications of diabetes with substances reactive with the fructosyl-lysine structure in glycated albuminEXOCELL INC·Filed 1994·Granted May 21, 1996·38 cites·9 claims
- 0475US5908925AGenetically engineered immunoglobulins with specificity for glycated albuminEXOCELL INC·Filed 1996·Granted Jun 1, 1999·31 cites·4 claims
- 0575US5494791AMonoclonal antibodies against glycated low density lipoproteinEXOCELL INC·Filed 1994·Granted Feb 27, 1996·46 cites·18 claims
- 0669US6355680B1Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologiesEXOCELL INC·Filed 1999·Granted Mar 12, 2002·23 cites·9 claims
- 0756US2008255236A1Methods and Composition Comprising 2-[(3-Chlorophenyl)Amino] Phenylacetic Acid for Alzheimer's DiseaseGLYCADIA INC·Filed 2008·Application pending·0 cites
- 0849US5183739AMonoclonal antibodies specific for non-a1c glycated hemoglobin and immunoassay methodsEXOCELL INC·Filed 1990·Granted Feb 2, 1993·9 cites·10 claims
- 0941US8962020B2Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acidCOHEN MARGO P·Filed 2012·Granted Feb 24, 2015·0 cites·11 claims
- 1039US2010035993A1Methods and compositions comprising 2-[(3-chlorophenyl) amino] phenylacetic acid for hyperpermeability and neovascularization disorders of the retinaCOHEN MARGO P·Filed 2008·Application pending·0 cites
- 1138US6001875AIn vivo methods of treatment to prevent kidney dysfunction using substances that inhibit albumin glycationEXOCELL INC·Filed 1998·Granted Dec 14, 1999·7 cites·8 claims
- 1237US5994401AIn Vivo Methods to reduce hypercholesterolemia and improve vascular dysfunctionEXOCELL INC·Filed 1998·Granted Nov 30, 1999·6 cites·7 claims
- 1333US2017157010A1Methods and compositions for treatment of disorders associated with damage induced by free radicalsCOHEN MARGO P·Filed 2015·Application pending·0 cites
- 1431US5312628AIsolation of a soluble 42 KD pancreatic islet cell autoantigenEXOCELL INC·Filed 1993·Granted May 17, 1994·2 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Margo P. Cohen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →